MedPAC Considers Part D Changes To Enhance Savings From Follow-On Biologics
This article was originally published in The Pink Sheet Daily
Executive Summary
At a recent meeting, the advisory group discussed the possibility that under the current Part D structure, the amount Medicare might save from follow-on biologics may be limited.
You may also be interested in...
Medicare Reimbursement Rates Would Be Set By New MedPAC Agency In Bill
Sen. Jay Rockefeller, D-W.Va., has adapted the concept of establishing an independent federal health care board modeled on the Federal Reserve in new legislation: his bill S. 1110 would convert the Medicare Payment Advisory Commission into an executive branch agency with expanded responsibilities
Medicare Reimbursement Rates Would Be Set By New MedPAC Agency In Bill
Sen. Jay Rockefeller, D-W.Va., has adapted the concept of establishing an independent federal health care board modeled on the Federal Reserve in new legislation: his bill S. 1110 would convert the Medicare Payment Advisory Commission into an executive branch agency with expanded responsibilities
Medicare Coverage For FOBs: MedPAC Weighs Least Costly Alternative, Coding Options
The Medicare Payment Advisory Commission is taking up payment issues for follow-on biologics as legislation establishing a regulatory pathway for approving such products gathers momentum in Congress.